ClinConnect ClinConnect Logo
Search / Trial NCT00642187

New Version Pulmicort Turbuhaler USA Adults

Launched by ASTRAZENECA · Mar 18, 2008

Trial Information

Current as of May 01, 2025

Completed

Keywords

Asthma Pulmicort Turbuhaler Budesonide Flexhaler

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Males and females at least 18 years old with a diagnosis of asthma (as defined by the ATS) for at least 6 months.
  • * To enter the run in period, subjects were also required to have the following:
  • A forced expiratory volume (FEV1) in 1 second of 60% to 90% of predicted normal, airway reversibility of at least 12% and 0.20 L, use of orally inhaled corticosteroids for at least 3 months prior to the study.
  • At Visit 2, subjects who met additional entry criteria related to rescue medication use and asthma symptom scores during the run in period plus visit specific FEV1 requirements were assigned to randomized treatments
  • Exclusion Criteria:
  • Life threatening asthma, Two or more overnight hospitalisations for asthma within 1 year or any emergency room visit for asthma within 6 months of starting study.
  • Use of steroid tablets or injections during the month (28 days) prior to Visit 1 and use of other asthma medicines (except rescue medication) within 2 weeks prior to the study.
  • Any acute exacerbation of asthma or a respiratory tract infection within 30 days prior to the study. Subject must not smoke or have smoked within 6 months of the study.

About Astrazeneca

AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Patients applied

0 patients applied

Trial Officials

Bertil Andersson

Study Director

AZ employee

Lars-Göran Carlsson

Study Director

AZ employee

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials